Log in

OTCMKTS:BIOAFbiOasis Technologies Stock Price, Forecast & News

$0.28
+0.01 (+3.70 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.28
Now: $0.28
$0.28
50-Day Range
$0.11
MA: $0.17
$0.29
52-Week Range
$0.09
Now: $0.28
$0.30
Volume1,000 shs
Average Volume36,933 shs
Market Capitalization$19.00 million
P/E RatioN/A
Dividend YieldN/A
Beta0.12
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's lead program is xB3-001, an xB3 peptide vector-trastuzumab fusion. It is developing xB3, a proprietary platform technology for the delivery of therapeutics and imaging agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders in the areas of high unmet medical needs, including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain metastases, glioblastomas, and neurodegenerative diseases. Bioasis Technologies Inc. has a collaborative research agreement with CQDM and Brain Canada to perform research on the delivery of therapeutic compounds across the BBB; and a strategic collaboration with BIOAGILYTIX for the development and validation of bioanalytical methods to support the xB3 TM-001 program, as well with WuXi Biologics (Hong Kong) Limited for the development and manufacturing of xB3-001 to treat cancer. The company was incorporated in 2006 and is headquartered in Guilford, Connecticut.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars


Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BIOAF
CUSIPN/A
CIKN/A
Phone203-533-7082

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$460,000.00
Book Value($0.01) per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$19.00 million
Next Earnings Date7/24/2020 (Estimated)
OptionableNot Optionable

Receive BIOAF News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOAF and its competitors with MarketBeat's FREE daily newsletter.

biOasis Technologies (OTCMKTS:BIOAF) Frequently Asked Questions

How has biOasis Technologies' stock been impacted by COVID-19 (Coronavirus)?

biOasis Technologies' stock was trading at $0.1545 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BIOAF shares have increased by 81.2% and is now trading at $0.28. View which stocks have been most impacted by Coronavirus.

When is biOasis Technologies' next earnings date?

biOasis Technologies is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for biOasis Technologies.

Has biOasis Technologies been receiving favorable news coverage?

Press coverage about BIOAF stock has trended very negative recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. biOasis Technologies earned a daily sentiment score of -3.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about biOasis Technologies.

Who are some of biOasis Technologies' key competitors?

Who are biOasis Technologies' key executives?

biOasis Technologies' management team includes the following people:
  • Dr. Deborah Ann Rathjen B.Sc. (Hons.), Q.C., Ph.D., M.A.I.C.D., FTSE, Exec. Chair, CEO & Pres (Age 61)
  • Ms. Christine Antalik, Chief Financial Officer (Age 48)
  • Mr. Graeme Dick, Director of Investor Relations
  • Mr. Kim Elton, Director of Marketing
  • Mr. Doug Williams MBA, Exec. VP & Chief Bus. Officer

What is biOasis Technologies' stock symbol?

biOasis Technologies trades on the OTCMKTS under the ticker symbol "BIOAF."

How do I buy shares of biOasis Technologies?

Shares of BIOAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is biOasis Technologies' stock price today?

One share of BIOAF stock can currently be purchased for approximately $0.28.

How big of a company is biOasis Technologies?

biOasis Technologies has a market capitalization of $19.00 million and generates $460,000.00 in revenue each year.

What is biOasis Technologies' official website?

The official website for biOasis Technologies is www.bioasis.us.

How can I contact biOasis Technologies?

biOasis Technologies' mailing address is 14 Water Street, Guilford CT, 6437. The company can be reached via phone at 203-533-7082 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.